News | News By Subject | News by Disease News By Date | Search News

Presbyopia News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News

News from Around the Web
No News Posted on that date

Press Releases
FDA Approves ReVision Optics, Inc.'s Implantable Device That Changes The Shape Of The Cornea To Correct Near Vision     6/30/2016
Encore Vision Announces Successful Phase I-II Study Of Topical EV06 For The Treatment Of Presbyopia     5/5/2016
Refocus Group (Formerly Presby) (RFCG) Completes Phase 3 Clinical Trial On The VisAbility Micro-Insert System For Presbyopia; Raises Additional Funding     5/5/2016
Encore Vision Announces Positive Results From The Phase I-II Study Of Topical EV06 For The Treatment Of Presbyopia     5/2/2016
Encore Vision, Inc. Announces First Subject Enrolled In Study Of Topical Treatment For Presbyopia     10/5/2015
Refocus Group (Formerly Presby) (RFCG) Presents Latest SSP Presbyopia Clinical Study Results At ESCRS     9/26/2005
Refocus Group (Formerly Presby) (RFCG) Receives FDA Approval To Initiate Final Phase Of SSP Clinical Trial For Presbyopia     8/24/2005
Refocus Group (Formerly Presby) (RFCG) Completes First Half Of Phase II Clinical Trial Surgeries For Presbyopia And Announces Preliminary Results     12/20/2004
Refocus Group (Formerly Presby) (RFCG) Profiled In New Clinica Report On Promising Presbyopia And Glaucoma Treatments     8/2/2004
Refocus Group (Formerly Presby) (RFCG) Reports Promising Initial Results In Ongoing Phase II Clinical Trials Of Presbyopia Treatment     7/21/2004
Refocus Group Officially Begins FDA Phase II Clinical Trials With Completion Of Initial Patient Procedures     2/23/2004
FDA Panel Recommends Approval Of Refractec, Inc.'s CK System For Presbyopic Patients Who Need Near Vision Improvement     2/9/2004
Refocus Group (Formerly Presby) (RFCG) Receives FDA Approval To Conduct Phase II Clinical Trials Of Surgical Treatment For Presbyopia     1/6/2004
Refocus Group (Formerly Presby) (RFCG) Secures $2.2 Million In Financing For FDA Phase II Clinical Trials And Continuing Operations     12/23/2003
Refocus Group (Formerly Presby) (RFCG) Files With FDA To Initiate Phase II Clinical Trials For Surgical Treatment Of Presbyopia     11/18/2003

//-->